CD44‐mediated Src Signaling in Endothelial Barrier Dysfunction

Rongqian Wu,Richard S. Beard,Xiaoxuan Cui,John Elliott,Mack H. Wu,Sarah Y. Yuan
DOI: https://doi.org/10.1096/fasebj.27.1_supplement.896.7
2013-01-01
Abstract:CD44 is a cell‐surface receptor for hyaluronan, a major glycosaminoglycan component of extracellular matrix. The objective of this study was to define the role of CD44 in endothelial barrier function and its downstream signal. Using cultured pulmonary microvascular endothelial cells, we found that blocking CD44 with high molecular weight HA (HMW‐HA) increased electric resistance in hydrogen peroxide‐stimulated endothelial monolayers, indicating a protective role of blocking endothelial CD44 signaling in the regulation of microvascular permeability. To confirm this finding in vivo, intravital microscopy was conducted in the rat mesentery. Our result showed that intravenous administration of HMW‐HA prevented plasma leak caused by the inflammatory mediator PAF. Western blot analysis indicated that oxidative stress and CD44 activator (i.e., CD44 antibody IM‐7) caused comparable Src activation (Y416 phosphorylation) in endothelial cells. The protective effect of HMW‐HA on endothelial barrier function was associated with inhibition of Src phosphorylation at Y416. Inhibition of Src activity by PP2, a selective inhibitor for Src‐family kinases, blocked CD44‐induced barrier dysfunction. Taken together, these results suggest that activation of endothelial CD44 increases microvascular permeability through Src phosphorylation. Supported by NIH RO1 HL061507, HL070752, GM097270 and HL096640.
What problem does this paper attempt to address?